Northstar Neuroscience Says It Has The Cash To Overcome EVEREST Setback
This article was originally published in The Gray Sheet
Executive Summary
Northstar Neuroscience says it has enough cash reserves to continue developing its cortical stimulation technology for tinnitus and depression, despite the disappointing results of the first pivotal trial for a stroke indication